Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Sofosbuvir
Price, profit and the Covid-19 health technology pool: The example of...
Christopher Garrison
-
May 28, 2020
The Power of TRIPS Flexibilities in Medicines Procurement
Ellen 't Hoen
-
April 9, 2018
Wrapping Up 2017 – some noteworthy medicines law and policy events.
Ellen 't Hoen
-
December 31, 2017
Medicines Excitement in the Netherlands – New Health Minister announces...
Ellen 't Hoen
-
November 24, 2017
Gilead’s sofosbuvir patent in India – options for global access to...
Ellen 't Hoen
-
May 26, 2016
This work is licensed under Creative Commons.